Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
The Endocrine Society today issued a Clinical Practice Guideline (CPG) for the diagnosis and treatment of polycystic ovary syndrome, the most common hormone disorder in women of reproductive age and a leading cause of infertility.
The CPG, entitled "Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline" will appear in the December 2013 issue of the Journal of Clinical Endocrinology and Metabolism (JCEM), a publication of The Endocrine Society.
Polycystic ovary syndrome, or PCOS, affects about 5 million women in the United States, according to the National Institutes of Health. The condition causes diverse symptoms, and its causes are poorly understood. The definition and even the name of PCOS have been subject to debate. An NIH panel concluded in January 2013 that the name's focus on a specific symptom - ovarian cysts - that is not present in all PCOS cases caused confusion about the condition. Three separate diagnostic classification systems have been developed to help identify PCOS.
"The Endocrine Society's CPG is designed to help physicians and patients navigate our evolving understanding of this complex condition," said Richard S. Legro, MD, of the Penn State University College of Medicine, and chair of the task force that authored the guideline. "The Society's recommendations allow physicians to make the diagnosis if clear symptoms are present without resorting to universal hormone tests or ultrasound screening."
In the CPG, The Endocrine Society recommends that a diagnosis be made if adult women have two of the three cardinal features of PCOS (diagnostic criteria supported by the NIH panel):
Other recommendations from the CPG include:
The Hormone Health Network, The Endocrine Society's public education arm, has published a fact sheet that explains how PCOS affects the body and outlines treatment options.
Other members of The Endocrine Society task force that developed this CPG include: Silva A. Arslanian of Children's Hospital of Pittsburgh; David A. Ehrmann of University of Chicago; Kathleen M. Hoeger of University of Rochester Medical Center in Rochester, NY; M. Hassan Murad of The Mayo Clinic in Rochester, MN; Renato Pasquali of Orsola-Malpighi Hospital in Bologna, Italy; and Corrine K. Welt of Massachusetts General Hospital in Boston, MA.
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Women's Health / Gynecology category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Society, The Endocrine. "Conflicting criteria clarified for diagnosing polycystic ovary syndrome." Medical News Today. MediLexicon, Intl., 29 Oct. 2013. Web.
10 Dec. 2013. <http://www.medicalnewstoday.com/releases/267952>
Society, T. (2013, October 29). "Conflicting criteria clarified for diagnosing polycystic ovary syndrome." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/267952.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.